Hidetake Amemiya

1.1k total citations
88 papers, 792 citations indexed

About

Hidetake Amemiya is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hidetake Amemiya has authored 88 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Surgery, 33 papers in Pulmonary and Respiratory Medicine and 29 papers in Oncology. Recurrent topics in Hidetake Amemiya's work include Gastric Cancer Management and Outcomes (22 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Metastasis and carcinoma case studies (11 papers). Hidetake Amemiya is often cited by papers focused on Gastric Cancer Management and Outcomes (22 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Metastasis and carcinoma case studies (11 papers). Hidetake Amemiya collaborates with scholars based in Japan, Netherlands and China. Hidetake Amemiya's co-authors include Hiroshi Kono, Naohiro Hosomura, Hiromichi Kawaida, Daisuke Ichikawa, Hideki Fujii, Masanori Matsuda, Masami Asakawa, Hideki Fujii, Akira Maki and Hidenori Akaike and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and American Journal Of Pathology.

In The Last Decade

Hidetake Amemiya

70 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetake Amemiya Japan 16 333 332 216 155 125 88 792
Takahiro Yoshikawa Japan 16 226 0.7× 247 0.7× 164 0.8× 112 0.7× 143 1.1× 69 716
Keinosuke Ishido Japan 16 279 0.8× 352 1.1× 164 0.8× 108 0.7× 64 0.5× 89 669
Daichi Ishikawa Japan 20 289 0.9× 207 0.6× 120 0.6× 340 2.2× 109 0.9× 48 851
Shöhei Iijima Japan 15 149 0.4× 269 0.8× 299 1.4× 126 0.8× 78 0.6× 57 752
Song Shi China 10 137 0.4× 219 0.7× 133 0.6× 192 1.2× 117 0.9× 16 634
Hisaaki Miyoshi Japan 16 249 0.7× 177 0.5× 93 0.4× 407 2.6× 191 1.5× 40 803
Donglin Sun China 19 266 0.8× 430 1.3× 250 1.2× 283 1.8× 149 1.2× 54 1.0k
Chengyong Qin China 19 217 0.7× 171 0.5× 139 0.6× 313 2.0× 257 2.1× 46 862
Diana Sacchi Italy 14 99 0.3× 253 0.8× 113 0.5× 181 1.2× 173 1.4× 27 637
Hidetsugu Yamagishi Japan 16 328 1.0× 258 0.8× 193 0.9× 244 1.6× 68 0.5× 62 806

Countries citing papers authored by Hidetake Amemiya

Since Specialization
Citations

This map shows the geographic impact of Hidetake Amemiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetake Amemiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetake Amemiya more than expected).

Fields of papers citing papers by Hidetake Amemiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetake Amemiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetake Amemiya. The network helps show where Hidetake Amemiya may publish in the future.

Co-authorship network of co-authors of Hidetake Amemiya

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetake Amemiya. A scholar is included among the top collaborators of Hidetake Amemiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetake Amemiya. Hidetake Amemiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Saito, Ryo�, Hidetake Amemiya, Wataru Izumo, et al.. (2025). Prognostic Significance of Splenic Vein Invasion for Pancreatic Cancer Patients With Pancreatectomy: A Retrospective Study. Anticancer Research. 45(2). 773–779.
3.
Kono, Hiroshi, Shinji Furuya, Hidetake Amemiya, Naohiro Hosomura, & Daisuke Ichikawa. (2025). Exosomes Isolated from Blood Induce Acute Lung Injury in a Rat Septic Peritonitis Model. Shock. 65(2). 239–249. 1 indexed citations
4.
Maruyama, Suguru, Katsutoshi Shoda, Yoshihiko Kawaguchi, et al.. (2025). Relationship Between Kyphosis and Postoperative Gastroesophageal Reflux After Proximal Gastrectomy. Annals of Gastroenterological Surgery. 9(5). 964–970. 1 indexed citations
5.
Shiraishi, Kensuke, Hiroki Shimizu, Makoto Sudo, et al.. (2024). Intraluminal washout in rectal and sigmoid colon cancer surgeries with double‐stapling technique anastomosis: A single‐institution prospective study. Annals of Gastroenterological Surgery. 9(1). 137–144.
6.
7.
Yamamoto, Atsushi, Hiroki Shimizu, Katsutoshi Shoda, et al.. (2024). The Expression and Role of Aquaporin 4 in Colon Cancer. Anticancer Research. 44(2). 567–573. 1 indexed citations
8.
Maruyama, Suguru, Katsutoshi Shoda, Yoshihiko Kawaguchi, et al.. (2024). Prognostic significance and risk factors of mediastinal lymph node metastasis in esophagogastric junction cancer: a single-center, retrospective study. Langenbeck s Archives of Surgery. 409(1). 346–346.
9.
Kono, Hiroshi, Naohiro Hosomura, Hidetake Amemiya, et al.. (2023). Recombinant Human Thrombomodulin Reduces Mortality and Acute Lung Injury Caused by Septic Peritonitis in Rats. ImmunoHorizons. 7(1). 159–167. 1 indexed citations
10.
Takahashi, Kazunori, Katsutoshi Shoda, Yudai Higuchi, et al.. (2023). Prognostic Impact of Stromal Profiles Educated by Gastric Cancer. Annals of Surgical Oncology. 31(4). 2309–2318.
11.
Kono, Hiroshi, Naohiro Hosomura, Hidetake Amemiya, et al.. (2021). Recombinant Human Thrombomodulin Has Additive Effects in Septic Patients Undergoing Continuous Hemodiafiltration Due to Intestinal Perforation. Shock. 56(3). 374–383. 1 indexed citations
12.
Saito, Ryo�, Hidetake Amemiya, Naohiro Hosomura, et al.. (2021). Stroke Volume Variation Monitoring to Minimize Blood Loss in Hepatocellular Carcinoma Resection. Anticancer Research. 41(1). 409–415.
13.
Yamamoto, Atsushi, Katsutoshi Shoda, Yoshihiko Kawaguchi, et al.. (2021). Prognostic impact of lymph node micrometastasis in patients with gastric cancer. Surgery Today. 52(1). 61–68. 5 indexed citations
14.
Shoda, Katsutoshi, Ryo� Saito, Suguru Maruyama, et al.. (2020). Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature. Surgery Today. 51(6). 849–861. 2 indexed citations
15.
Ashizawa, Naoki, Hiroki Shimizu, Makoto Sudo, et al.. (2019). Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer. Anticancer Research. 39(8). 4405–4410. 5 indexed citations
16.
Saito, Ryo�, Hidetake Amemiya, Naohiro Hosomura, et al.. (2019). Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection. Anticancer Research. 39(6). 3033–3038. 17 indexed citations
17.
Kawaida, Hiromichi, Hiroshi Kono, Mitsuaki Watanabe, et al.. (2015). Pancreaticoduodenectomy for pancreas carcinoma occurring in the annular pancreas: report of a case. Clinical Journal of Gastroenterology. 8(4). 223–227. 4 indexed citations
18.
Amemiya, Hidetake, Masanori Matsuda, Masami Asakawa, Naohiro Hosomura, & Hideki Fujii. (2011). A case of untreated poorly differentiated hepatocellular carcinoma of 1.9 cm in diameter. Kanzo. 52(3). 184–192. 1 indexed citations
19.
Amemiya, Hidetake, et al.. (2009). A Case of Inflammatory Myofibroblastic Tumor Coexisted with Colon Cancer. The Japanese Journal of Gastroenterological Surgery. 42(5). 577–582. 1 indexed citations
20.
Amemiya, Hidetake, et al.. (2008). A CASE OF PNEUMATOSIS CYSTOIDES INTESTINALIS WITH PNEUMOPERITONEUM INDUCED BY .ALPHA.-GLUCOSIDASE INHIBITOR. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(8). 2034–2037. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026